Cite

HARVARD Citation

    Ikeda, G. et al. (2022). The safety of current treatment options for advanced esophageal cancer after first-line chemotherapy. Expert opinion on drug safety. 21 (1), pp. 55-65. [Online]. 
  
Back to record